Neomycin Ear Drops Suppliers & Bulk Manufacturers
Available Forms: Ear drops
Available Strengths: 0.3%
Reference Brands: Neosporin Otic(US)
Category:
ENT
Neomycin ear drops are an aminoglycoside antibiotic that inhibits bacterial protein synthesis, effectively treating susceptible ear infections. They eliminate bacteria, reduce inflammation, and prevent complications such as otitis externa and media. Benefits include rapid infection resolution, symptom relief, and protection of ear health when used appropriately under medical supervision.
Neomycin ear drops is available in Ear drops
and strengths such as 0.3%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Neomycin ear drops is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Neomycin ear drops can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Neomycin ear drops, marketed as Neosporin Otic, are regulated as topical antimicrobial agents in the US by the FDA and in the EU via EMA. Approval requires dossiers covering safety, efficacy, manufacturing practices, and pharmacovigilance. In the US, the FDA reviews clinical and quality data, while the EMA ensures compliance with regional safety standards. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and broad availability for bacterial ear infection treatment worldwide, helping prevent complications and resistance when used under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing